Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

被引:168
作者
Gonzalez-Juanatey, Carlos
Llorca, Javier
Miranda-Filloy, Jose A.
Amigo-Diaz, Encarnacion
Testa, Ana
Garcia-Porrua, Carlos
Martin, Javier
Gonzalez-Gay, Miguel A.
机构
[1] Hosp Xeral Calde, Div Rheumatol, Lugo 27004, Spain
[2] Univ Cantabria, Sch Med, E-39005 Santander, Spain
[3] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain
来源
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2007年 / 57卷 / 02期
关键词
psoriatic arthritis; cardiovascular disease; atherosclerosis; endothelial dysfunction;
D O I
10.1002/art.22530
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective.. To determine whether endothelial dysfunction was present in a cohort of patients with psoriatic arthritis (PsA) without overt cardiovascular disease or classic cardiovascular risk factors attended to in a community hospital. Methods. Fifty patients with PsA who fulfilled the Moll and Wright criteria were recruited from Hospital Xeral-Calde (Lugo, Spain). Patients seen during the period of recruitment who had classic cardiovascular risk factors or had experienced cardiovascular or cerebrovascular events were excluded. Fifty healthy matched controls were also studied. In all patients and controls, endothelial function was determined by measuring flow-mediated endothelial dependent vasodilatation (FMD%) and endothelial independent vasodilatation (GTN%) by brachial ultrasonography. Results. FMD% was significantly impaired in patients compared with controls (mean, median [range] 6.3%, 6.1% [0.3-13.4%] versus 8.2%, 8.2% [0.0-21.2%]; P = 0.008). However, no significant difference existed between patients and controls in GTN% or baseline diameter. A significant correlation between C-reactive protein level and erythrocyte sedimentation rate at the time of disease diagnosis and FMD% was found (P < 0.04). No significant FMD% and GTN% differences were observed when patients with PsA with polyarticular pattern were compared with the remaining patients with PsA. Conclusion. The present study demonstrates that patients with PsA without cardiovascular risk factors or clinically evident cardiovascular disease also exhibit endothelial dysfunction. These observations provide a basis for the potential association between PsA and atherosclerotic disease.
引用
收藏
页码:287 / 293
页数:7
相关论文
共 35 条
[1]   Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension [J].
Brunner, H ;
Cockcroft, JR ;
Deanfield, J ;
Donald, A ;
Ferrannini, E ;
Halcox, J ;
Kiowski, W ;
Luscher, TF ;
Mancia, G ;
Natali, A ;
Oliver, JJ ;
Pessina, AC ;
Rizzoni, D ;
Rossi, GP ;
Salvetti, A ;
Spieker, LE ;
Taddei, S ;
Webb, DJ .
JOURNAL OF HYPERTENSION, 2005, 23 (02) :233-246
[2]   Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery - A report of the International Brachial Artery Reactivity Task Force [J].
Corretti, MC ;
Anderson, TJ ;
Benjamin, EJ ;
Celermajer, D ;
Charbonneau, F ;
Creager, MA ;
Deanfield, J ;
Drexler, H ;
Gerhard-Herman, M ;
Herrington, D ;
Vallance, P ;
Vita, J ;
Vogel, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (02) :257-265
[3]   Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension [J].
Deanfield, J ;
Donald, A ;
Ferri, C ;
Giannattasio, C ;
Halcox, J ;
Halligan, S ;
Lerman, A ;
Mancia, G ;
Oliver, JJ ;
Pessina, AC ;
Rizzoni, D ;
Rossi, GP ;
Salvetti, A ;
Schiffrin, EL ;
Taddei, S ;
Webb, DJ .
JOURNAL OF HYPERTENSION, 2005, 23 (01) :7-17
[4]   Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects [J].
del Rincón, I ;
Williams, K ;
Stern, MP ;
Freeman, GL ;
O'Leary, DH ;
Escalante, A .
ARTHRITIS AND RHEUMATISM, 2003, 48 (07) :1833-1840
[5]  
del Rincón I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO
[6]  
2-#
[7]   Psoriatic arthritis: epidemiology, clinical features, course, and outcome [J].
Gladman, DD ;
Antoni, C ;
Mease, P ;
Clegg, DO ;
Nash, P .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 :14-17
[8]  
Gladman DD, 1998, ARTHRITIS RHEUM-US, V41, P1103, DOI 10.1002/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO
[9]  
2-N
[10]   Discussion: Clinical features, epidemiology, classification criteria, and quality of life in psoriasis and psoriatic arthritis [J].
Gladman, DD .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 :24-25